NanoString Appoints Todd Garland as Chief Commercial Officer
August 28 2023 - 5:53AM
Business Wire
NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life
science tools for discovery and translational research, today
announced that Todd Garland has been appointed Chief Commercial
Officer, effective August 28, 2023.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230826560279/en/
NanoString Appoints Todd Garland as Chief
Commercial Officer (Photo: Business Wire)
Mr. Garland is a senior executive with more than 25 years of
experience in healthcare and life sciences technologies that serve
customers in the discovery, translational and clinical markets.
Most recently Mr. Garland served as Chief Commercial Officer at
Cytek Biosciences, a leading provider of flow cytometry products
and services. Prior to joining Cytek, Mr. Garland spent 6 years at
BD Biosciences, a $1.2 billion life sciences tools company, as Vice
President and General Manager responsible for all commercial
functions including marketing, sales, service and support. Before
joining BD Biosciences, Mr. Garland was Vice President of Sales at
CareFusion, a medical device company. From 2003-2009, Mr. Garland
held a variety of commercial leadership roles at Cardinal Health.
Mr. Garland earned his BS degree in accounting from California
Polytechnic State University and an MBA from the University of
Michigan.
“I’m thrilled to have Todd joining the team to lead our
commercial efforts at a time of explosive growth in spatial
biology,” said Bray Gray, President and CEO of NanoString. “Todd
has an outstanding track record of developing great teams and
delivering strong results. Our global commercial team has a lot of
momentum behind it and Todd is ready to lead the charge.”
“I have long admired NanoString’s mission of developing
breakthrough technologies that help our scientific community better
understand the biology of disease. I’m extremely excited to be
joining this team of dedicated and passionate professionals to help
drive adoption of spatial biology which will advance scientific
discovery and lead to the development of new treatments that will
ultimately improve the human condition,” said Todd Garland.
NanoString also announced today, as required by Nasdaq Stock
Market Rules, equity inducement awards to Mr. Garland and 16 other
new employees.
In accordance with Nasdaq Listing Rule 5635(c)(4), the
Compensation and Human Capital Committee of NanoString’s Board of
Directors approved the grant of the following equity award to Mr.
Garland as a material inducement to Mr. Garland entering into
employment with NanoString: effective as of August 28, 2023, the
first day of his employment with NanoString, an award of 200,000
restricted stock units, or RSUs. In addition, if there is a change
in control and if upon or during the 12 months after such change in
control, Mr. Garland’s employment is terminated either (i) by
NanoString without cause or (ii) by him for good reason, 100% of
the unvested RSUs will become fully vested as of the termination of
his employment. In addition, the Compensation and Human Capital
Committee approved the grant of, in the aggregate, 59,983 RSUs to
16 employees as material inducements to their entrance into
employment with NanoString, effective as of September 5, 2023.
For all of the aforementioned equity inducement awards,
one-third of the RSUs vest on the first market trading day on or
following the first anniversary of the effective date of grant and
one-third of the RSUs vest annually each year on the first market
trading day on or after the second and third anniversaries of the
effective date of grant, subject to each employee’s continued
service through each such date.
The inducement RSU awards were made outside of NanoString’s
current stockholder approved equity plan, the 2022 Equity Incentive
Plan, and under NanoString’s 2018 Inducement Equity Incentive Plan
and related award agreements, but will be subject to terms and
conditions generally consistent with those in the 2022 Equity
Incentive Plan.
About NanoString Technologies, Inc.
NanoString Technologies, a leader in spatial biology, offers an
ecosystem of innovative discovery and translational research
solutions, empowering our customers to map the universe of biology.
The GeoMx® Digital Spatial Profiler is a flexible and consistent
solution combining the power of whole tissue imaging with gene
expression and protein data for spatial whole transcriptomics and
proteomics. The CosMx™ Spatial Molecular Imager is a single-cell
imaging platform powered by spatial multiomics enabling researchers
to map single cells in their native environments to extract deep
biological insights and novel discoveries from one experiment. The
AtoMx™ Spatial Informatics Platform is a cloud-based informatics
solution with advanced analytics and global collaboration
capabilities, enabling powerful spatial biology insights anytime,
anywhere. At the foundation of our research tools is our nCounter®
Analysis System, which offers a secure way to easily profile the
expression of hundreds of genes, proteins, miRNAs, or copy number
variations, simultaneously with high sensitivity and precision.
For more information, please visit www.nanostring.com.
The NanoString logo, NanoString, NanoString Technologies, GeoMx,
CosMx, AtoMx and nCounter are trademarks or registered trademarks
of NanoString Technologies, Inc., in various jurisdictions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230826560279/en/
Doug Farrell Vice President, Investor Relations &
Corporate Communications dfarrell@nanostring.com
NanoString Technologies (NASDAQ:NSTG)
Historical Stock Chart
From Apr 2024 to May 2024
NanoString Technologies (NASDAQ:NSTG)
Historical Stock Chart
From May 2023 to May 2024